EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to commercialize FDA-approved treatment for post-amputation pain

Proceeds will be used to support U.S. commercialization of Altius®, a direct electrical nerve stimulation system designed to treat chronic, intractable post-amputation pain in adult amputees Post-amputation pain is a severely underserved indication, affecting up to 80% of amputees in the...